CompletedPhase 2NCT01200732
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
Studying Eisenmenger syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Govind Ballabh Pant Hospital
- Principal Investigator
- Saibal Mukhopadhyay, M.D;D.MGBPant Hospital
- Intervention
- Tadalafil, placebo(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- Govind Ballabh Pant Hospital(GB Pant Hospital), New Delhi, New Delhi, India
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01200732 on ClinicalTrials.govOther trials for Eisenmenger syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07356778A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator TherapyKazuya Hosokawa
- RECRUITINGNANCT05611268Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger SyndromeUniversity of Sao Paulo General Hospital